Minerals Technologies Inc. — Q3 2012 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2012; comparable periods ended October 2, 2011. Financial statements are unaudited and were reviewed, not audited, by KPMG.
Business context and results
Minerals Technologies operates through Specialty Minerals and Refractories, serving paper, steel, construction, and other industrial markets. All dollar amounts below are in millions unless stated otherwise.
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Net sales | $250.3 | $262.2 | $761.5 | $793.1 |
| Income from operations | $27.8 | $25.4 | $84.3 | $75.2 |
| Consolidated net income | $19.2 | $16.3 | $58.0 | $50.2 |
| Net income attributable to MTI | $18.6 | $15.7 | $56.4 | $47.9 |
| Diluted EPS | $1.05 | $0.87 | $3.17 | $2.62 |
Q3 sales declined 5%; management attributed approximately $11.6 million, or 4 percentage points, of the decrease to unfavorable foreign exchange. Nine-month sales fell 4%, including an approximately $23.4 million adverse foreign-exchange impact. Despite lower revenue, Q3 operating income rose 10% and MTI-attributable net income rose 19%; for nine months, operating income increased 12% and MTI-attributable net income increased 18%.
Margins, segments, cash flow, and financial position
- Margins: Production margin was 22.0% of sales in Q3 versus 20.2% a year earlier; operating margin was 11.1% versus 9.7%; net income margin was 7.4% versus 6.0%. Nine-month production margin was 21.8% versus 20.1%, and operating margin was 11.1% versus 9.5%.
- Segments: Q3 Specialty Minerals sales were $165.6 million, down 3%, while operating income increased to $22.6 million from $19.3 million. Refractories sales were $84.7 million, down 7%, and operating income was $7.2 million versus $7.5 million. For nine months, segment operating income increased 13% in each segment: Specialty Minerals to $64.6 million and Refractories to $25.0 million.
- Cash flow: Nine-month operating cash flow was $104.8 million versus $92.9 million. Capital expenditures were $37.8 million; operating cash flow less capital expenditures was approximately $66.9 million. Management reported Q3 operating cash flow of approximately $40 million.
- Liquidity: September 30 cash and cash equivalents were $449.1 million, with $12.7 million in short-term investments. Management cited approximately $462 million combined, a 4.4 current ratio, and $191 million of uncommitted credit lines, of which $5.1 million was drawn.
- Debt: Total debt was approximately $90.8 million, including short-term debt, current maturities, and long-term debt; long-term debt alone was $83.8 million. Total debt declined from approximately $99.8 million at year-end 2011, including repayment of $8.0 million of revenue bonds in August. Management reported an 11% debt-to-equity ratio.
- Capital returns: The company paid $2.7 million in common dividends during the nine months and repurchased 197,315 shares for $11.7 million under its $75 million, two-year authorization. The declared dividend was $0.05 per share per quarter.
Management commentary, outlook, and risks
Management described performance as solid despite weakening economic conditions in Europe. It highlighted 11 commercial agreements for its FulFill higher-filler technology and a contract for a 100,000-ton satellite PCC facility in China. It also cited a new laser measurement system for the steel industry. These initiatives are part of its growth strategy; the filing provides no earnings or revenue guidance and cautions that implementation may not succeed.
Management expected 2012 capital expenditures of $55–$65 million, principally for PCC plants and strategic growth opportunities. It expected financing needs to be met through internally generated funds, uncommitted credit lines, and, where appropriate, project financing. Debt maturities included $77.2 million in 2013 and $8.2 million in 2014.
- Key operating exposures include uncertain global conditions, softer steel markets, lower paper production in North America and Europe, customer shutdowns or financial distress, industry consolidation and pricing pressure, raw-material availability and costs, energy prices, and foreign-exchange movements.
- NewPage bankruptcy proceedings could expose the company to an impairment charge of up to $16 million and additional bad-debt provisions if the plan fails or supplied mills close. The company recorded no impairment in Q3 based on its assessment at the time. 2011 sales to NewPage locations were approximately $20 million.
- The Alizay, France paper mill was not operating; if it cannot be sold, MTI may permanently close its PCC satellite facility and incur an impairment. The facility’s net book value was $3.7 million; 2011 sales were approximately $7 million.
- Environmental matters included accrued estimated remediation costs of $0.4 million each for the Canaan, Connecticut site and the Adams, Massachusetts site. Potential future wastewater-treatment upgrades at Adams were preliminarily estimated at $6–$8 million; the timing and final cost remain uncertain.
- There were 72 pending silica cases and 29 pending asbestos cases. Management did not expect these matters to materially affect financial position or results, but claims’ merits and potential amounts were generally unclear. At least 25 asbestos cases were described as eligible for full indemnification under agreements with Pfizer.
- Pension funding, benefit-cost estimates, and asset returns remain sensitive to market conditions. The company expected 2012 contributions of $15 million to pension plans and $1 million to other post-retirement plans.
Most important facts for investors to verify
- Whether sales weakness in Europe and the steel and paper markets persists, and how much future revenue remains exposed to foreign exchange.
- Whether FulFill commercial agreements and the China PCC facility convert into sustained volume and earnings growth.
- Developments in the NewPage bankruptcy and Alizay mill sale, including potential asset impairment and receivable exposure.
- Actual capital spending versus the $55–$65 million estimate, and refinancing or repayment of the $77.2 million debt maturity in 2013.
- Final remediation requirements and costs at Canaan and Adams, and changes in silica/asbestos claims or indemnification.